Visualize Bacteria in Diabetic Foot Ulcers with the MolecuLight i:X™

85% of non-traumatic lower limb amputations are preceded by a foot ulcer.1 Many of these amputations are preventable through regular foot exams, detection and management of infection, and regular debridement.2 Real-time visualization of potentially harmful bacteria with the MolecuLight i:X can help clinicians detect and manage bacterial load through guided debridement, guided cleaning, and appropriate use of antimicrobial dressings.

visualize-bacteria-in-diabetic-foot-ulcers-standard-imaging-mode
Image taken prior to cleaning and debridement in Standard Imaging ModeTM
visualize-bacteria-in-diabetic-foot-ulcers-fluorescent-imaging-mode
Image taken prior to cleaning and debridement in Fluorescence Imaging ModeTM (presence of bacteria indicated by red color)

Patient Testimonial: “I check my feet every night. I have since I was a little girl. I have my husband double check my feet. I woke up and the wound was there. It wasn’t there when I went to bed. It seemed to be responding to treatment but all of a sudden things changed. It was getting bigger and then it started getting black. And I thought ‘this is going to be it, I’m going to lose the foot.’

Having a device that can see where the bacteria is, it gives me peace of mind knowing I can see it and the images help me better understand. It’s been an important part of my wound care, absolutely.”

Wound Etiology
  • Diabetic foot ulcer (open for 7 months)
Anatomical Location
  • Left heel
Patient Demographics
  • Female, 54 years old
Patient-Specific Challenges
  • Diabetic (> 40 years)
Patient’s General Care Paradigm
  • Antibacterial ointment and dressings
  • Collagenase cream
  • Hyperbaric oxygen therapy
Clinician Stated Utility of the MolecuLight i:X
  • Guided debridement and cleaning
  • Avoid the need for swabs
Images provided by Rose Raizman RN-EC, MSc, Rouge Valley Health System, ON, Canada
MolecuLight Clinical Case 0039.

1. Singh N et al, Preventing Foot Ulcers in Patients With Diabetes JAMA, 2005; 293(2):217-228.
2. Canadian Diabetes Association 2013 Clinical Practice Guidelines.